期刊文献+

果胶基口服结肠靶向给药系统的研究进展 被引量:1

Progress on pectin-based oral colon-specific drug delivery system
下载PDF
导出
摘要 果胶具有安全无毒、可生物降解和良好的生物相容性等特点成为药物缓释载体的常用材料。简要综述了果胶基口服结肠靶向给药系统的研究进展,并对其发展趋势进行了展望。 Pectin has excellent properties such as : safety-non toxic, high stability, good biocompatibility, etc, so it is widely used for drug controlled release carriers. In this article, the recent progress on pectin-based oral colon-specific drug delivery system is reviewed, and the prospects of its development trend is pointed out.
出处 《现代化工》 CAS CSCD 北大核心 2011年第2期25-28,共4页 Modern Chemical Industry
基金 国家自然科学基金项目(20864001)资助
关键词 果胶基 结肠靶向 药物载体 pectin-based colon-specific drug carrier
  • 相关文献

参考文献20

  • 1Kakoulides E P, Smart J D, Tsibauklis J. Azocrosslinked poly ( acrylic acid) for colonic delivery and adhesion specificity: In vitro degradation and preliminary ex vivo bioadhesion studies [ J ]. Journal of Controlled Release,1998,54( 1 ) :95 - 109.
  • 2Liu L S,Fishman M L,Kost J,et al. Pectin-based systems for colonspecific drug delivery via oral route [ J ]. Biomaterials, 2003,24 (19) :3333 -3343.
  • 3Hiorth M, Kjiniksen A L, Knudsen K D, et al. Structural and dynamieal properties of aqueous mixtures of pectin and ehitosan[ J]. European Polymer Journal, 2005,41 ( 8 ) : 1718 - 1728.
  • 4Ali E A, Alarifi A. Characterization and in vitro evaluation of starch based hydrogels as carriers for colon specific drug delivery systems [ J ]. Carbohydrate Polymers,2009,78 (4) :725 - 730.
  • 5Varshosaza J, Emami J, Tavakoli N, et al. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis [ J ]. International Journal of Pharmaceutics ,2009,365 ( 1/2 ) :69 - 76.
  • 6陈建海,陈清源,沈家瑞.新型结肠定位给药系统偶氮聚合物的合成与细菌降解(英文)[J].中山大学学报(自然科学版),2003,42(A19):91-94. 被引量:3
  • 7Schols H A, Bakx E J, Schipper D, et al. A xylogalacturonan subunit present in the modified hairy regions of apple pectin[ J]. Carbohydrate Research, 1995,279:265 - 279.
  • 8张文博,高林,施秀芳,张启来.高效体积排阻色谱法测定改性柑橘果胶的分子质量[J].色谱,2007,25(5):711-714. 被引量:12
  • 9Wei X L, Sun N Y. Sigmoidal release of indomethacin from pectin matrix tablets:Effect of in situ crosslinking by calcium cations[ J]. International Journal of Pharmaceutics, 2006,318 ( 1/2 ) : 132 - 138.
  • 10Wellner N, Kacurakova M, Malovikova A,et al. FT-IR study of pectate and pectinate gels formed by divalent cations [ J ]. Journal of Controlled Release, 1998,308 ( 1/2 ) : 123 - 131.

二级参考文献25

  • 1雷激,马力,赵义梅,邹立,许杰.低温碱法脱酯制取低酯果胶的研究[J].食品与发酵工业,2006,32(1):45-48. 被引量:28
  • 2Kakoulides E P, Smart J D, Tsibouklis J. Azocross-linked poly(acrylic acid) for colonic delivery and adhesion specifity:synthesis and characterization[J]. J Contr Rel, 1998, 52:291 - 300.
  • 3Rubinstein A,Radai R, Ezra M, et al. In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carder[J]. Pharm Res, 1993, 10:258 - 263.
  • 4Rubinstein A, Nakar D, Sintov A. Colonic drug delivery:enhanced release of indomethacin from cross linked chondroitin matrix in rat cecal content[J]. Pharm Res, 1992,9: 276 - 278.
  • 5Larsen C, Harboe E, Johansen M, et al. Macromolecular prodrugs. XV. Colon-targeted delivery: comparison of the rate of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal tract[J]. Pharm Res, 1989, 6: 995 - 999.
  • 6Friend D R. Oral colon-specific Drug delivery. Boca Raton,Florida: CRC Press.
  • 7White G W, Katona T, Zodda J P. J Pharra Biomed Anal, 1999, 20(6) : 905.
  • 8Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, Raz A. J Natl Cancer hast, 2002, 94 (24) : 1854.
  • 9Zhang L, Li X, Xu X, Zeng F. Carbohydr Res, 2005, 340 (8) :1515.
  • 10Liu H, Geng M, Xin X, Li F, Zhang Z, Li J, Ding J. Glycobiology, 2005, 15(5) : 501.

共引文献17

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部